This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry from Switzerland by market capitalization with links to their reference stock.
Rank | Company | Market Cap (USD) | Country | Sector | Industry |
---|---|---|---|---|---|
1 | Vifor Pharma AG |
$11.57 B
(Dec. 1, 2022) |
Switzerland | Healthcare | Drug Manufacturers—Specialty & Generic |
2 | Siegfried Holding AG | $4.20 B | Switzerland | Healthcare | Drug Manufacturers—Specialty & Generic |
3 | PolyPeptide Group AG | $664.2 M | Switzerland | Healthcare | Drug Manufacturers—Specialty & Generic |
4 | El.En. SpA |
$5.1 M
(July 1, 2023) |
Switzerland | Healthcare | Drug Manufacturers—Specialty & Generic |
5 | SES Solar, Inc. | Switzerland | Healthcare | Drug Manufacturers—Specialty & Generic |
Company Profile:
Vifor Pharma AG
Market Cap (USD):
$11.57 B
(Dec. 1, 2022)
Country:
Switzerland
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
Siegfried Holding AG
Market Cap (USD):
$4.20 B
Country:
Switzerland
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
PolyPeptide Group AG
Market Cap (USD):
$664.2 M
Country:
Switzerland
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
El.En. SpA
Market Cap (USD):
$5.1 M
(July 1, 2023)
Country:
Switzerland
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Company Profile:
SES Solar, Inc.
Country:
Switzerland
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic